NanoSphere Health Sciences Inc. (CSE: NSHS)
Canada
· Delayed Price · Currency is CAD
0.0600
-0.0250 (-29.41%)
Dec 19, 2024, 2:35 PM EST
CSE: NSHS Statistics
Total Valuation
NanoSphere Health Sciences has a market cap or net worth of CAD 616,512. The enterprise value is 643,732.
Market Cap | 616,512 |
Enterprise Value | 643,732 |
Important Dates
The next estimated earnings date is Monday, April 28, 2025.
Earnings Date | Apr 28, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
NanoSphere Health Sciences has 10.28 million shares outstanding.
Current Share Class | n/a |
Shares Outstanding | 10.28M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 2.52% |
Owned by Institutions (%) | n/a |
Float | 7.20M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -2.39 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.01
Current Ratio | 0.01 |
Quick Ratio | 0.01 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -162.01 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -541.10% |
Return on Capital (ROIC) | n/a |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +500.00% in the last 52 weeks. The beta is -0.24, so NanoSphere Health Sciences's price volatility has been lower than the market average.
Beta (5Y) | -0.24 |
52-Week Price Change | +500.00% |
50-Day Moving Average | 0.03 |
200-Day Moving Average | 0.03 |
Relative Strength Index (RSI) | 64.01 |
Average Volume (20 Days) | 4,449 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -245,122 |
Pretax Income | -268,874 |
Net Income | -268,874 |
EBITDA | n/a |
EBIT | -245,122 |
Earnings Per Share (EPS) | -0.03 |
Balance Sheet
The company has 15,959 in cash and 43,174 in debt, giving a net cash position of -27,215 or -0.00 per share.
Cash & Cash Equivalents | 15,959 |
Total Debt | 43,174 |
Net Cash | -27,215 |
Net Cash Per Share | -0.00 |
Equity (Book Value) | -2.28M |
Book Value Per Share | -0.22 |
Working Capital | -2.28M |
Cash Flow
Operating Cash Flow | -41,935 |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
NanoSphere Health Sciences does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | n/a |
FCF Yield | n/a |
Stock Splits
The last stock split was on July 7, 2021. It was a reverse split with a ratio of 0.05.
Last Split Date | Jul 7, 2021 |
Split Type | Reverse |
Split Ratio | 0.05 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |